By activating caspase 8, a SPARC N‐terminal peptide may improve the apoptotic cascade and resensitize chemotherapy‐resistant human colon, breast, and pancreatic cancer cells to treatment [17]. The gene discussed is SPARC; the disease is pancreatic neoplasm.